{"id":"NCT02536755","sponsor":"Genzyme, a Sanofi Company","briefTitle":"Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 Studies","officialTitle":"Open Label Interventional Multicenter Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Successfully Completed the Phase 2 or Phase 3 Studies","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-10-27","primaryCompletion":"2021-06-24","completion":"2021-06-24","firstPosted":"2015-09-01","resultsPosted":"2022-07-15","lastUpdate":"2022-07-15"},"enrollment":31,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gaucher Disease"],"interventions":[{"type":"DRUG","name":"Eliglustat, GZ385660","otherNames":["Cerdelga"]}],"arms":[{"label":"Eliglustat","type":"EXPERIMENTAL"}],"summary":"Primary Objective:\n\nEvaluate long term skeletal response to eliglustat in adult participants who successfully completed one of the Phase 2 or Phase 3 eliglustat studies.\n\nSecondary Objective:\n\nEvaluate the safety of eliglustat (by serious adverse event continuous monitoring), the quality of life (Short Form-36 Health Survey \\[SF-36\\]) and biomarkers of Gaucher disease type 1 (GD1) (chitotriosidase, plasma glucosylceramide \\[GL-1\\] and lyso glucosylceramide \\[lyso-GL-1\\]) in adult participants who successfully completed one of the Phase 2 or Phase 3 studies.","primaryOutcome":{"measure":"Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208","timeFrame":"Study Baseline, Weeks 52, 104, 156 and 208","effectByArm":[{"arm":"Eliglustat","deltaMin":31,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":4,"countries":["Canada","Russia","Tunisia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":31},"commonTop":["Pregnancy","Iron Deficiency Anaemia","Toothache","Human Chorionic Gonadotropin Increased","Arthralgia"]}}